FR2354092A1 - Tretinoine dans un excipient de gel pour le traitement de l'acne - Google Patents

Tretinoine dans un excipient de gel pour le traitement de l'acne

Info

Publication number
FR2354092A1
FR2354092A1 FR7600725A FR7600725A FR2354092A1 FR 2354092 A1 FR2354092 A1 FR 2354092A1 FR 7600725 A FR7600725 A FR 7600725A FR 7600725 A FR7600725 A FR 7600725A FR 2354092 A1 FR2354092 A1 FR 2354092A1
Authority
FR
France
Prior art keywords
acne
treatment
gel
tretinoine
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7600725A
Other languages
English (en)
French (fr)
Other versions
FR2354092B1 (en:Method
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson
Original Assignee
Johnson and Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson filed Critical Johnson and Johnson
Publication of FR2354092A1 publication Critical patent/FR2354092A1/fr
Application granted granted Critical
Publication of FR2354092B1 publication Critical patent/FR2354092B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FR7600725A 1975-01-17 1976-01-13 Tretinoine dans un excipient de gel pour le traitement de l'acne Granted FR2354092A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54190675A 1975-01-17 1975-01-17

Publications (2)

Publication Number Publication Date
FR2354092A1 true FR2354092A1 (fr) 1978-01-06
FR2354092B1 FR2354092B1 (en:Method) 1981-09-18

Family

ID=24161582

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7600725A Granted FR2354092A1 (fr) 1975-01-17 1976-01-13 Tretinoine dans un excipient de gel pour le traitement de l'acne

Country Status (18)

Country Link
AT (1) AT363191B (en:Method)
AU (1) AU499339B2 (en:Method)
BE (1) BE837662A (en:Method)
CA (1) CA1063515A (en:Method)
DE (1) DE2601489A1 (en:Method)
DK (1) DK157781C (en:Method)
FI (1) FI56931B (en:Method)
FR (1) FR2354092A1 (en:Method)
GB (1) GB1476717A (en:Method)
IN (1) IN142640B (en:Method)
LU (1) LU74195A1 (en:Method)
NL (1) NL7600388A (en:Method)
NO (1) NO760149L (en:Method)
NZ (1) NZ179755A (en:Method)
PH (1) PH18090A (en:Method)
PT (1) PT64709B (en:Method)
SE (1) SE429924B (en:Method)
ZA (1) ZA76251B (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004052353A3 (en) * 2002-12-12 2004-07-15 Galderma Res & Dev Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4214000A (en) 1978-10-30 1980-07-22 Johnson & Johnson Zinc salt of all-trans-retinoic acid for the treatment of acne
JPS58164508A (ja) * 1982-03-26 1983-09-29 Eisai Co Ltd イソプレニルカルボン酸含有外用組成物
CH655656B (en:Method) * 1982-10-07 1986-05-15
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
MY105521A (en) * 1989-04-17 1994-10-31 Healthpoint Ltd Moisturizing vehicle for topical application of vitamin a acid.
JP2671248B2 (ja) * 1991-10-23 1997-10-29 ブロック・ドラッグ・カンパニー・インコーポレイテッド 薬効または化粧効果成分の浸透性増進方法
GB9125712D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Skin care composition
AU670777B2 (en) * 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
GB2268402A (en) * 1992-06-19 1994-01-12 Ian Donald Morrison Compositions for treating skin disorders
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
CN100464741C (zh) * 2002-12-12 2009-03-04 盖尔德马研究及发展公司 含有酚衍生物和类维生素a的含水醇脱色素凝胶
FR2857266B1 (fr) * 2003-07-07 2007-09-21 Jean Noel Thorel Composition a usage dermatologique et/ou cosmetique, comprenant a titre de principe actif au moins un antioxydant lipophile
JP2008534514A (ja) * 2005-03-24 2008-08-28 アナコール ファーマシューティカルズ，インコーポレイテッド ボリン酸抗生物質の局所製剤およびそれらの使用法
US20100215700A1 (en) 2009-02-25 2010-08-26 Conopco, Inc., D/B/A Unilever Shear Gels and Compositions Comprising Shear Gels
CN118121574A (zh) * 2022-12-02 2024-06-04 南京毓浠医药技术有限公司 一种含维a酸组合物及其制备方法和用途
CN119925334A (zh) * 2023-11-06 2025-05-06 南京毓浠医药技术有限公司 一种含有氨甲环酸与维a酸的复方组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL257621A (en:Method) * 1959-11-23
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004052353A3 (en) * 2002-12-12 2004-07-15 Galderma Res & Dev Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid
JP2006510652A (ja) * 2002-12-12 2006-03-30 ガルデルマ・リサーチ・アンド・デヴェロップメント・エス・エヌ・セ フェノール誘導体およびレチノイド含有水−アルコール脱色ゲル
JP2010095534A (ja) * 2002-12-12 2010-04-30 Galderma Research & Development フェノール誘導体およびレチノイド含有水−アルコール脱色ゲル

Also Published As

Publication number Publication date
FI760089A7 (en:Method) 1976-07-18
DK157781B (da) 1990-02-19
SE7600436L (sv) 1976-07-18
GB1476717A (en) 1977-06-16
PH18090A (en) 1985-03-20
BE837662A (fr) 1976-07-16
ATA27276A (de) 1980-12-15
ZA76251B (en) 1977-08-31
IN142640B (en:Method) 1977-08-06
NO760149L (en:Method) 1976-07-20
DE2601489A1 (de) 1976-07-22
NZ179755A (en) 1978-06-20
DE2601489C2 (en:Method) 1990-02-01
FR2354092B1 (en:Method) 1981-09-18
LU74195A1 (en:Method) 1976-05-18
PT64709B (fr) 1978-01-04
SE429924B (sv) 1983-10-10
AU1035176A (en) 1977-07-21
DK18276A (da) 1976-07-18
PT64709A (fr) 1976-02-01
NL7600388A (nl) 1976-07-20
FI56931B (fi) 1980-01-31
CA1063515A (en) 1979-10-02
AT363191B (de) 1981-07-10
DK157781C (da) 1990-08-13
AU499339B2 (en) 1979-04-12

Similar Documents

Publication Publication Date Title
FR2354092A1 (fr) Tretinoine dans un excipient de gel pour le traitement de l'acne
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
FR2562539B1 (fr) Nouveaux derives de l'acide vinyl-4 benzoique, leur procede de preparation et leurs applications en therapeutique et comme ligands
FR2768927B1 (fr) Utilisation de l'acide ellagique, de ses sels, de ses complexes metalliques, de ses derives mono- ou poly-ethers, mono- ou poly-acyles dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie
DE69429822D1 (de) Abschuppende zusammensetzung von salicylsäure und zwitterionischen verbindungen
AU3202595A (en) 1,2-substituted imidazolyl compounds for the treatment of inflammation
FR2378523A1 (fr) Medicament pour le traitement de l'acne
Gomez Actions of isotretinoin and etretinate on the pilosebaceous unit
FR2450107A1 (fr) Nouvelles compositions detergentes cosmetiques et pharmaceutiques a base de sarcosine
NO885172L (no) Nye topiske metronidazolpreparater og terapeutiske anvendelser derav.
IT1272290B (it) Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
IT1274156B (it) "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
ATE268587T1 (de) Gebrauch von silicongummi zur stabilisierung von ascorbinsaüre und vorbereitungen die diese zusammensetzungen enthalten
MX9203739A (es) Complejo organico de oro aplicado topicamente.
CA2199995A1 (fr) Utilisation du 2,4-diamino pyrimidine 3-oxyde ou de l'un de ses sels dans le traitement des desordres de la maturation et de la structuration du collagene
US4868219A (en) Treatment of skin diseases with aliphatic amines
TR199700694T1 (xx) D vitamini t�revlerinin dermotolojik kullan�m�.
ATE234071T1 (de) Gegen akne und entzündete comedonen wirksame wirkstoffkombinationen
EP0262334A3 (de) Entzündungshemmende Mittel
IT1274157B (it) "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
DE59002738D1 (de) Kombinationspräparate enthaltend Chloramphenicol, Gentamicin und Nystatin als aktive Wirkstoffe zur topischen Behandlung entzündlicher Hauterkrankungen.
RU95115760A (ru) Состав для лечения ран, ожогов, аллергических контактных дерматитов
CY1107814T1 (el) Θεραπεια παθησεων υπερπολλαπλασιασμου των επιφανειων του σωματος
FR2362862A1 (fr) Nouvelle enzyme proteolytique, sa preparation et son emploi a l'epilage des peaux
FR2694694B1 (fr) Composition active pour le traitement du psoriasis, notamment le psoriasis du cuir chevelu.